Myriad Genetics has been in business for more than 27 years and we are a global leader in personalized medicine.  Click on the image below to download our midyear FY2019 fact sheet.

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.